Pfizer Inc. filed suit against Johnson & Johnson alleging it has thwarted biosimilar competition to its arthritis drug Remicade by effectively preventing health insurers, hospitals and clinics from offering Pfizer’s lower-priced copy.
Trump’s HHS seeks to encourage health-care competition.
Health insurers will receive this month’s payments from the Trump administration reimbursing them for reducing copayments and deductibles for millions of low-income customers, the White House said, once more shelving a standoff with insurers over the contested funds.
Since the Republican effort to repeal and replace most of the Affordable Care Act faltered in July, three major efforts have emerged in the Senate as lawmakers seek a path forward. Here are some key details of the three proposals.
The Vermont Socialist talks Democrats into admitting they want to kill private health plans.
As Sen. Bernie Sanders unveils his single-payer health program, we look at how such a plan would work and the political landscape that will greet it.
Recent advances have made 3-D printing more useful for planning surgery and creating drugs.
New research from Princeton economist Alan Krueger suggests a significant portion of the decline in labor-force participation among Americans in their prime working years could be linked to the opioid epidemic.
Democrats and activists are trying to promote the Affordable Care Act’s open-enrollment period after the Trump administration cut millions of dollars from programs that help people sign up for coverage.
Merck KGaA Chief Executive Stefan Oschmann put the Germany company’s consumer-health unit on the block in a move that will focus its health-care activities on the riskier business of developing prescription medicines.
A deadline for insurers to file 2018 prices for health insurance sold through Affordable Care Act exchanges arrives Tuesday, but state regulators are still struggling to make decisions about pricing and coverage amid uncertainty in federal-health policy.
A breakdown in the supply of prescription drugs and medical equipment was one of several problems that health officials and hospital chief executives discussed as they plotted a way out of the crisis.
A number of Senate Republicans are gathering behind a bipartisan push to shore up the Affordable Care Act, reflecting a growing divide between President Donald Trump and many GOP senators.
State officials are increasingly worried that this year’s turbulent health-care politics in Washington could threaten funding for the Children’s Health Insurance Program, a popular that usually wins broad bipartisan support.
The Advisory Board will be split up and sold in a deal worth around $2.21 billion, with its health-care business going to UnitedHealth and its education unit to private-equity firm Vista Equity Partners.
Jason Furman and Bob Kocher claim a single bundled fee based on quality measures is the solution. Their approach is one size fits all that is designed to rein in cost and theoretically improve care. This isn’t the solution
When providers split a fixed fee—say, for a knee replacement—patients get only a single bill.
President Donald Trump named Tomas Philipson, an economist at the University of Chicago who has specialized in health-care policy, to the three-member Council of Economic Advisers on Monday.
If President Trump revokes the congressional ObamaCare exemption, Congress may refuse to vote for health-care legislation he proposes. So what exactly is the downside here?
I met with both Sens. King and Collins’s staffs. I am grateful that they listened to me.